ArticleInternational journal of retina and vitreous2025
Transconjunctival suprachoroidal buckling for rhegmatogenous retinal detachment.
Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo assess the effectiveness of the transconjunctival suprachoroidal buckle (TSCB) technique in treating primary rhegmatogenous retinal detachment (RRD).
methodsA prospective interventional study including patients with primary RRD undergoing the TSCB technique. The technique consisted of a transconjunctival approach using an olive tip handled cannula with an Atkinson 25-gauge needle tip that injects a high-purity gel in the suprachoroidal space (SCS) and creates a buckle effect that lasts for 12–18 months. Indirect laser retinopexy is done in the operating room or in the early post-operative office visit on the slit lamp. The TSCB technique could be done in the office in selected cases of uncomplicated RRD.
resultsThe study included 31 eyes of 31 patients. Seventeen eyes were phakic (55%). The RRD involved one quadrant in 81% of eyes. Sixteen eyes (52%) had more than one break. The TSCB procedure was performed in the operating room in 21 patients (68%). The mean duration of follow-up was 5 months. Postoperatively, we achieved retinal attachment in all patients. Three patients (10%) needed a second surgery. Two patients (6%) developed dot hemorrhage due to choroidal puncture.
conclusionThe TSCB is safe, and avoids the complications of conventional scleral buckling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.